The CNS Specific Antisense Oligonucleotide market is witnessing transformative growth driven by advancements in gene therapy targeting neurological disorders. As precision medicine gains traction, this industry size is expanding rapidly, reflecting significant shifts in treatment protocols and patient outcomes. Market trends indicate escalating investments and innovations catalyzing b... https://hallbook.com.br/blogs/834056/CNS-Specific-Antisense-Oligonucleotide-Market-Size-and-Trends-Driving-Rapid